EGFR and lung adenocarcinoma: Total of 301 patients with stage Ia-IIIa resected lung adenocarcinomas whose survival had been identified were retrospectively analyzed.Their EGFR mutations were detected by real-time quantitative PCR and DNA sequencing technology together.